Antibody-RNA Conjugates represent a significant advancement in the treatment of challenging and rare diseases with unmet medical need.

miRecule, a biotechnology company developing RNA therapies, and GBI Biomanufacturing, a CDMO, entered a strategic partnership to advance the development and clinical supply of miRecule’s Antibody-RNA ...

Recule, a biotechnology company pioneering RNA therapies, and GBI Biomanufacturing, a leading contract development and manufacturing organization (CDMO), today announced a strategic partnership to ...

PLANTATION, Fla. and GAITHERSBURG, Md., Jan. 28, 2025 /PRNewswire/ -- miRecule, a biotechnology company pioneering RNA therapies, and GBI Biomanufacturing, a leading ...

(MENAFN- PR Newswire) Under the agreement, GBI will leverage its expertise and state-of-the-art facilities to support miRecule in the development and clinical production of its ARC therapies.

PLANTATION, Fla. and GAITHERSBURG, Md., Jan. 28, 2025 /PRNewswire/ -- miRecule, a biotechnology company pioneering RNA therapies, and GBI Biomanufacturing, a leading contract development and ...

Pricefx, the global leader in AI-powered SaaS pricing software, today announced the release of version 14.0 of its award-winning pricing platform. The new version, Caribou Lou, brings new AI ...

Vantaca, the leading community association management software provider, is thrilled to announce the addition of four distinguished executives to its team: Tom Arnett as Chief Strategy Officer, John ...